Shengrong Lin

1.1k total citations
18 papers, 845 citations indexed

About

Shengrong Lin is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Shengrong Lin has authored 18 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Shengrong Lin's work include Cancer Genomics and Diagnostics (6 papers), RNA Research and Splicing (5 papers) and RNA modifications and cancer (3 papers). Shengrong Lin is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), RNA Research and Splicing (5 papers) and RNA modifications and cancer (3 papers). Shengrong Lin collaborates with scholars based in China, United States and Germany. Shengrong Lin's co-authors include Xiang‐Dong Fu, Shatakshi Pandit, Dong Wang, Ran Xiao, Michael G. Rosenfeld, Ye Sun, Xue Li, Jianhua Ding, Xiangdong Xu and Peiqing Sun and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Shengrong Lin

17 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengrong Lin China 9 711 187 65 56 54 18 845
Eva M. Riising Denmark 7 752 1.1× 171 0.9× 51 0.8× 70 1.3× 48 0.9× 7 829
Philippe Thibault Canada 14 1.1k 1.6× 283 1.5× 40 0.6× 65 1.2× 95 1.8× 17 1.3k
Ching-Man Virbasius United States 8 593 0.8× 100 0.5× 30 0.5× 106 1.9× 88 1.6× 9 711
Chiara Vardabasso United States 9 740 1.0× 120 0.6× 56 0.9× 159 2.8× 83 1.5× 12 873
Timothée Revil Canada 13 878 1.2× 172 0.9× 64 1.0× 81 1.4× 75 1.4× 19 1.0k
Sílvia Carvalho Portugal 6 670 0.9× 125 0.7× 45 0.7× 42 0.8× 36 0.7× 7 735
Sonia Couture Canada 12 824 1.2× 267 1.4× 24 0.4× 42 0.8× 58 1.1× 14 902
Anne Gibaud France 14 471 0.7× 100 0.5× 54 0.8× 85 1.5× 63 1.2× 26 635
Hui Liang China 9 540 0.8× 132 0.7× 27 0.4× 122 2.2× 68 1.3× 17 631
F. Paulin United Kingdom 12 665 0.9× 111 0.6× 52 0.8× 182 3.3× 27 0.5× 14 826

Countries citing papers authored by Shengrong Lin

Since Specialization
Citations

This map shows the geographic impact of Shengrong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengrong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengrong Lin more than expected).

Fields of papers citing papers by Shengrong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengrong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengrong Lin. The network helps show where Shengrong Lin may publish in the future.

Co-authorship network of co-authors of Shengrong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Shengrong Lin. A scholar is included among the top collaborators of Shengrong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengrong Lin. Shengrong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Pengpeng, et al.. (2023). Revealing the role of regulatory T cells in the tumor microenvironment of lung adenocarcinoma: a novel prognostic and immunotherapeutic signature. Frontiers in Immunology. 14. 1244144–1244144. 20 indexed citations
2.
Bao, Yun, et al.. (2023). Abstract 259: Fully automated targeted sequencing sample prep on open platform liquid handlers. Cancer Research. 83(7_Supplement). 259–259. 1 indexed citations
4.
Lin, Shengrong, Shengjie Zhou, Xin Han, et al.. (2023). Single-cell analysis reveals exosome-associated biomarkers for prognostic prediction and immunotherapy in lung adenocarcinoma. Aging. 15(20). 11508–11531.
6.
Zhao, Grace, et al.. (2022). A novel NGS kit solution for multi-cancer early detection using circulating cell free DNA based methylation analysis.. Journal of Clinical Oncology. 40(16_suppl). 10542–10542. 2 indexed citations
8.
Hu, Bao‐Shan, et al.. (2017). Feasibility of interlaminar lumbar discectomy through percutaneous transforaminal endoscopy and blunt perforation of the ligamentum flavum. Turkish Neurosurgery. 28(5). 716–722. 1 indexed citations
9.
Xu, Ting, Xiaozheng Kang, Xiaofang You, et al.. (2017). Cross-Platform Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient Plasma. Theranostics. 7(6). 1437–1446. 68 indexed citations
10.
Li, Min, Weiwei Xiao, Grace Zhao, et al.. (2017). Predictive value of circulating tumor DNA in locally advanced rectal cancer patients receiving neoadjuvant radiochemotherapy.. Journal of Clinical Oncology. 35(15_suppl). e15125–e15125. 4 indexed citations
11.
Shen, Wei Feng, Grace Zhao, Zhonglin Liang, et al.. (2016). Retrospective analysis of circulating tumor DNA of archived plasma samples.. Journal of Clinical Oncology. 34(15_suppl). e23175–e23175. 1 indexed citations
12.
Li, Zhengrong, Daojiang Li, Guoyang Zhang, et al.. (2014). Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer.. PubMed. 4(6). 648–62. 42 indexed citations
13.
Wang, Wenyi, Peidong Shen, Shengrong Lin, et al.. (2010). Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing. Nucleic Acids Research. 39(1). 44–58. 19 indexed citations
14.
Lin, Shengrong, Wenyi Wang, Curtis Palm, Ronald W. Davis, & Kara Juneau. (2010). A molecular inversion probe assay for detecting alternative splicing. BMC Genomics. 11(1). 712–712. 5 indexed citations
15.
Lin, Shengrong, et al.. (2008). The splicing factor SC35 has an active role in transcriptional elongation. Nature Structural & Molecular Biology. 15(8). 819–826. 290 indexed citations
16.
Xiao, Ran, Ye Sun, Jianhua Ding, et al.. (2007). Splicing Regulator SC35 Is Essential for Genomic Stability and Cell Proliferation during Mammalian Organogenesis. Molecular and Cellular Biology. 27(15). 5393–5402. 129 indexed citations
17.
Lin, Shengrong & Xiang‐Dong Fu. (2007). SR Proteins and Related Factors in Alternative Splicing. Advances in experimental medicine and biology. 623. 107–122. 164 indexed citations
18.
Lin, Shengrong, Ran Xiao, Peiqing Sun, Xiangdong Xu, & Xiang‐Dong Fu. (2005). Dephosphorylation-Dependent Sorting of SR Splicing Factors during mRNP Maturation. Molecular Cell. 20(3). 413–425. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026